| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.910 | 3.582 | 10.116 | 12.335 | 13.928 | 16.451 |
| Total Income - EUR | - | - | - | - | 2.910 | 3.582 | 10.116 | 12.335 | 13.928 | 16.451 |
| Total Expenses - EUR | - | - | - | - | 3.174 | 3.733 | 7.414 | 8.390 | 15.533 | 6.711 |
| Gross Profit/Loss - EUR | - | - | - | - | -264 | -151 | 2.702 | 3.945 | -1.606 | 9.740 |
| Net Profit/Loss - EUR | - | - | - | - | -351 | -255 | 2.404 | 3.678 | -2.208 | 8.214 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alesiana Imedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 125 | 0 | 1.484 |
| Current Assets | - | - | - | - | 94 | 4.640 | 1.853 | 5.341 | 7.865 | 10.408 |
| Inventories | - | - | - | - | 0 | 45 | 1.123 | 2.107 | 2.101 | 0 |
| Receivables | - | - | - | - | 36 | 781 | 34 | 34 | 1.171 | 1.828 |
| Cash | - | - | - | - | 59 | 3.814 | 696 | 3.199 | 4.593 | 8.580 |
| Shareholders Funds | - | - | - | - | -429 | -676 | 1.743 | 5.427 | 3.202 | 11.491 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 524 | 5.317 | 109 | 40 | 4.662 | 422 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alesiana Imedica S.r.l.